RxDoctor Payments Data

Marcus Knapp, PA

Physician Assistant · Watertown, NYNPI 1861429995

Payments from drug & device makers

$387in general payments, 2019–2025

Across 17 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$72
  • AstraZeneca$56
  • Amgen$48
  • Grifols USA, LLC$47
  • Regeneron Healthcare Solutions, Inc.$45
  • Johnson & Johnson$38
  • plus $81 from 4 others

What the payments were for

  • Food & beverage$387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$387 in reported general payments places this provider in the 60th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$22,738
Medicare patients
246
Services billed
559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter209$164,718
Dupixent SyringeDupilumab22$98,308
Breo ElliptaFluticasone/Vilanterol112$64,197
Dupixent PenDupilumab13$57,382
Incruse ElliptaUmeclidinium Bromide134$53,629
Spiriva RespimatTiotropium Bromide52$34,839
Arnuity ElliptaFluticasone Furoate79$28,440
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$28,113
Advair HfaFluticasone Propion/Salmeterol42$22,990
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$19,487
SymbicortBudesonide/Formoterol Fumarate62$18,651
Fluticasone-SalmeterolFluticasone Propion/Salmeterol126$16,338
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$15,718
Spiriva HandihalerTiotropium Bromide28$14,888
Advair DiskusFluticasone Propion/Salmeterol23$6,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta, Anoro Ellipta$72$330,472563 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$23$50,55764 claims
AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler$56$49,754110 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Watertown

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →